Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Combination of Ublituximab, TGR-1202, and Bendamustine Demonstrates Significant Activity in Patients with Advanced DLBCL and Follicular Lymphoma

Matthew Lunning, DO, Philip J Bierman, MD, R. Gregory Bociek, MD, Marshall T. Schreeder, MD, Susan Blumel, RN, BSN, Kathy Cutter, RN, BSN, Emily K. Pauli, BMBS, PharmD, Peter Sportelli, Hari P. Miskin, MS, Michael S. Weiss, Julie M Vose, MD

Blood (2016) 128 (22): 4197.

https://doi.org/10.1182/blood.V128.22.4197.4197

Published: 2016

Journal Articles

Risk-Adapted Therapy in Adults with Burkitt Lymphoma: Preliminary Report of a Multicenter Prospective Phase II Study of DA-EPOCH-R

Blood (2015) 126 (23): 342.

https://doi.org/10.1182/blood.V126.23.342.342

Published: 2015

Journal Articles

Use of Low Molecular Weight Heparin (LMWH) in Thrombocytopenic Patients with Hematologic Malignancy-Associated Venous Thromboembolism (VTE)

Nabin Khanal, MBBS, R. Gregory Bociek, MD, Baojiang Chen, PhD, Julie M. Vose, MD, James O. Armitage, MD, Philip J Bierman, MD, Lori J. Maness, MD, Matthew A. Lunning, DO, Krishna Gundabolu, MD, Vijaya R. Bhatt, MD

Blood (2015) 126 (23): 3482.

https://doi.org/10.1182/blood.V126.23.3482.3482

Published: 2015

Journal Articles

Tolerability and Efficacy of Treatments in Elderly Patients with Hodgkin Lymphoma: A Report from the Nebraska Lymphoma Study Group

Roberto A. Ferro, MD, Vijaya R. Bhatt, MD, Martin Bast, BS, Lynette Smith, MS, R. Gregory Bociek, MD, Matthew A. Lunning, DO, Philip J Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD

Blood (2015) 126 (23): 1504.

https://doi.org/10.1182/blood.V126.23.1504.1504

Published: 2015

Journal Articles

Rituximab Added to Aggressive Chemotherapy Improves the Outcome of Patients with Follicular Lymphoma, Grade 3 and Results In Survival Comparable to Diffuse Large B-Cell Lymphoma.

Philip J. Bierman, MD, Julie M. Vose, MD, R. Gregory Bociek, MD, Fausto R. Loberiza, Jr., MD, MS, Martin Bast, BS, James O. Armitage, MD

Blood (2010) 116 (21): 2810.

https://doi.org/10.1182/blood.V116.21.2810.2810

Published: 2010

Journal Articles

The Impact of Histological Subtypes on Outcome in Patients with Mantle Cell Lymphoma Treated with or without Autologous Stem Cell Transplant.

Muhammad I. Zulfiqar, MBBS, Dennis D. Weisenburger, MD, Fausto R. Loberiza, MD, Julie M. Vose, MD, Philip J. Bierman, MD, R. Gregory Bociek, MD, James O. Armitage, MD

Blood (2007) 110 (11): 1904.

https://doi.org/10.1182/blood.V110.11.1904.1904

Published: 2007

Journal Articles

Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype.

Julie M. Vose, MD, John C. Chan, MD, Philip J. Bierman, MD, Alejandro Arevalo, MD, Fausto Loberiza, MD, Kai Fu, MD, Dennis Weisenburger, MD, Robert G. Bociek, MD, Martin Bast, BS, James O. Armitage, MD

Blood (2007) 110 (11): 3430.

https://doi.org/10.1182/blood.V110.11.3430.3430

Published: 2007

Journal Articles

Outcomes of Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).

John D. Dickinson, MD, PhD, Fausto Loberiza, MD, Victoria Whalen, Philip J. Bierman, MD, Julie M. Vose, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, James O. Armitage, MD, Greg Bociek, MD

Blood (2007) 110 (11): 3045.

https://doi.org/10.1182/blood.V110.11.3045.3045

Published: 2007

Journal Articles

Differential Expression of Hem1 and CTLA-4 in B-CLL Patients with High and Low CD38 Expression.

Avadhut D. Joshi, B.Pharm, John D. Dickinson, PhD, James C. Lynch, PhD, Philip J. Bierman, MD, Gregory R. Bociek, MD, Marcel P. Devetten, MD, James O. Armitage, MD, Shantaram S. Joshi, PhD

Blood (2005) 106 (11): 2103.

https://doi.org/10.1182/blood.V106.11.2103.2103

Published: 2005

Journal Articles

Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning.

Apar Kishor Ganti, MD, Stephanie J. Lee, MD, MPH, James O. Armitage, MD, Philip J. Bierman, MD, Gregory Bociek, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Elizabeth C. Reed, MD, Julie M. Vose, MD, Fausto Loberiza, MD, MS

Blood (2005) 106 (11): 2025.

https://doi.org/10.1182/blood.V106.11.2025.2025

Published: 2005

Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

R. Gregory Bociek, MD, MSc, James E. Talmadge, PhD, James C. Lynch, PhD, Charles A. Enke, MD, Charles A. Kuszynski, PhD, Philip J. Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Timothy R. McGuire, PhD, James L. Wisecarver, MD, Shantaram S. Joshi, PhD, Zivko S. Pavletic, MD

Blood (2005) 106 (11): 3671.

https://doi.org/10.1182/blood.V106.11.3671.3671

Published: 2005

Journal Articles

Factors Affecting the Development of Atrial Fibrillation and Atrial Flutter (AF) Following Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT).

Mary Lee H. Villanueva, MD, Fausto R. Loberiza, MD, MS, James O. Armitage, MD, Robert G. Bociek, MD, Apar Kishor Ganti, MD, James C. Lynch, PhD, Farhan Majeed, MD, Stefano R. Tarantolo, MD, Jo Torrey, RN, BSN, Julie M. Vose, MD, Philip J. Bierman, MD

Blood (2005) 106 (11): 1754.

https://doi.org/10.1182/blood.V106.11.1754.1754

Published: 2005

Journal Articles

Combined Chemotherapy and Radiation Is Associated with Improved Outcomes in Stage I Follicular Lymphoma.

Apar Kishor Ganti, MD, R. Gregory Bociek, MD, Philip J. Bierman, MD, James C. Lynch, Ph.D., Martin A. Bast, BS, Julie M. Vose, MD, James O. Armitage, MD

Blood (2004) 104 (11): 4567.

https://doi.org/10.1182/blood.V104.11.4567.4567

Published: 2004

Journal Articles

Gene Expression in CLL Cells Associated with Lymphadenopathy and Chromosome 11q23 Deletion.

John D. Dickinson, BA, Avadhut Joshi, BS, Jamie Gilmore, BS, Philip J. Bierman, MD, Sanger Warren, PhD, Shantaram S. Joshi, PhD

Blood (2004) 104 (11): 971.

https://doi.org/10.1182/blood.V104.11.971.971

Published: 2004

Journal Articles

Autologous Transplant Event-Free Survival (EFS) Following Failure of CHOP-Rituximab (CHOP-R) for Diffuse Large B-Cell Lymphoma (DLBCL) Is the Same as the EFS Following Failure of CHOP Alone.

Julie M. Vose, MD, Philip J. Bierman, MD, James C. Lynch, PhD, Gregory Bociek, MD, James O. Armitage, MD

Blood (2004) 104 (11): 890.

https://doi.org/10.1182/blood.V104.11.890.890

Published: 2004

Journal Articles

Patients with Follicular Lymphoma, Grade 3, Have a Prolonged Relapse-Free Survival Following Aggressive Combination Chemotherapy.

Apar Kishor Ganti, MD, Dennis D. Weisenburger, MD, Lynette M. Smith, MS, Christine P. Hans, MD, R. Gregory Bociek, MD, Philip J. Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD, The Nebraska Lymphoma Study Group

Blood (2004) 104 (11): 613.

https://doi.org/10.1182/blood.V104.11.613.613

Published: 2004

NARROW

Combination of Ublituximab, TGR-1202, and Bendamustine Demonstrates Significant Activity in Patients with Advanced DLBCL and Follicular Lymphoma

Risk-Adapted Therapy in Adults with Burkitt Lymphoma: Preliminary Report of a Multicenter Prospective Phase II Study of DA-EPOCH-R

Use of Low Molecular Weight Heparin (LMWH) in Thrombocytopenic Patients with Hematologic Malignancy-Associated Venous Thromboembolism (VTE)

Tolerability and Efficacy of Treatments in Elderly Patients with Hodgkin Lymphoma: A Report from the Nebraska Lymphoma Study Group

Rituximab Added to Aggressive Chemotherapy Improves the Outcome of Patients with Follicular Lymphoma, Grade 3 and Results In Survival Comparable to Diffuse Large B-Cell Lymphoma.

The Impact of Histological Subtypes on Outcome in Patients with Mantle Cell Lymphoma Treated with or without Autologous Stem Cell Transplant.

Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype.

Outcomes of Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).

Differential Expression of Hem1 and CTLA-4 in B-CLL Patients with High and Low CD38 Expression.

Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning.

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

Factors Affecting the Development of Atrial Fibrillation and Atrial Flutter (AF) Following Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT).

Combined Chemotherapy and Radiation Is Associated with Improved Outcomes in Stage I Follicular Lymphoma.

Gene Expression in CLL Cells Associated with Lymphadenopathy and Chromosome 11q23 Deletion.

Autologous Transplant Event-Free Survival (EFS) Following Failure of CHOP-Rituximab (CHOP-R) for Diffuse Large B-Cell Lymphoma (DLBCL) Is the Same as the EFS Following Failure of CHOP Alone.

Patients with Follicular Lymphoma, Grade 3, Have a Prolonged Relapse-Free Survival Following Aggressive Combination Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only